APOGEE ENTERPRISES, INC. 4

4 · APOGEE ENTERPRISES, INC. · Filed Jan 7, 2014

Form 4

Period: 2014-01-03

Director

Transactions

Exercise/Conversion
Common Stock
2014-01-03$28.10/sh+6,072$170,623→ 45,320 total
Exercise/Conversion
Common Stock
2014-01-03$15.05/sh+9,311$140,131→ 39,248 total
Exercise/Conversion
Common Stock
2014-01-03$18.31/sh+10,000$183,100→ 55,320 total
Sale
Common Stock
2014-01-03$34.78/sh−25,383$882,727→ 29,937 total
Exercise/Conversion
Director Option (Right to Buy)
2014-01-03−6,072→ 0 total
Exercise: $28.10Exp: 2017-06-27→ Common Stock (6,072 underlying)
Exercise/Conversion
Director Option (Right to Buy)
2014-01-03−9,311→ 0 total
Exercise: $15.05Exp: 2016-06-28→ Common Stock (9,311 underlying)
Exercise/Conversion
Director Option (Right to Buy)
2014-01-03−10,000→ 0 total
Exercise: $18.31Exp: 2018-06-25→ Common Stock (10,000 underlying)

Footnotes (3)

[F1]Includes restricted stock awards under the 2009 Non-Employee Director Stock Incentive Plan.
[F2]Currently 100% exercisable.
[F3]The price reported is the weighted average purchase price for the transactions reported. The prices paid ranged from $34.72 to $34.9810. The Reporting Person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range.

Documents

1 file